eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers in Oncology Portfolio News / Karina Tin November 24, 2021 eFFECTOR Therapeutics Announces Publication of Zotatifin Preclinical Data in Frontiers in Oncology Read More »
Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021, the Annual Meeting of the American Association for the Study of Liver Diseases Portfolio News / Karina Tin November 15, 2021 Surrozen Presents Data Supporting Potential of SZN-043 at The Liver Meeting 2021, the Annual Meeting of the American Association for the Study of Liver Diseases Read More »
Surrozen Reports Third Quarter 2021 Financial Results Portfolio News / Karina Tin November 15, 2021 Surrozen Reports Third Quarter 2021 Financial Results Read More »
Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference Portfolio News / Karina Tin November 12, 2021 Nurix Therapeutics Presents Beneficial Effects of CBL-B Inhibition on Human Tumor Infiltrating Lymphocytes at SITC Conference Read More »
Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors Portfolio News / Karina Tin November 12, 2021 Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors Read More »
A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 Portfolio News / Karina Tin November 12, 2021 A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 Read More »
RAPT Therapeutics Reports Third Quarter 2021 Financial Results Portfolio News / Karina Tin November 10, 2021 RAPT Therapeutics Reports Third Quarter 2021 Financial Results Read More »
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates Portfolio News / Karina Tin November 10, 2021 Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates Read More »
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress Portfolio News / Karina Tin November 10, 2021 Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress Read More »
eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update Portfolio News / Karina Tin November 8, 2021 eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update Read More »
